Factors Driving Duration to Cross-Selling in Non-Life Insurance: New Empirical Evidence from Switzerland
نویسندگان
چکیده
Customer relationship management and marketing analytics have become critical for non-life insurers operating in highly competitive markets. As it is easier to develop an existing customer than acquire a new one, cross-selling retention are key activities. In this research, we focus on both car household-liability insurance products consider the time owning only single product takes before buying other at same insurer. Based longitudinal consumer data from Swiss company covering period 2011 2015, aim study factors driving duration cross-selling. Given different dynamics observed products, separately cohorts. Considering framework of survival analysis, provide descriptive statistics Kaplan–Meier estimates along major characteristics, contract history distribution channel usage. For econometric analysis duration, compare results Cox accelerated failure models. We able characterize times related behavior through several covariates. Our indicate that policyholder age, place residence, premium, number contracts held, initial access used contracting influence particular, our underline importance tied agent differences geographic region urbanicity residence. By quantifying effects above factors, extend understanding basis developing models actions companies.
منابع مشابه
Age and Choice in Health Insurance: Evidence from Switzerland
Elements of regulation inherent in most social health insurance systems are a uniform package of benefits and uniform cost sharing. Both elements risk to burden the population with a welfare loss if preferences differ. This suggests introducing more contracted choice; however, it is widely believed that this would not benefit the aged. This study examines the relationship between age and willin...
متن کاملGenetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom.
OBJECTIVES To gather empirical evidence on any discrimination based on genetic information shown by the insurance industry in the United Kingdom and to assess how society is likely to handle future genetic information from tests for polygenic multifactorial conditions. DESIGN Postal questionnaire survey. SUBJECTS Sample (n=7000) of members from seven British support groups for families with...
متن کاملevidence of adverse selection in irans health insurance market
در این تحقیق به مطالعه وجود انتخاب نامساعد(کژ گزینی) در بازار بیمه درمان تکمیلی ایران پرداخته شده است. داده های مورد نیاز توسط پرسشنامه و به روش نمونه گیری خوشه ای جمع آوری شده است. پرسشنامه ها در میان افراد شاغل ساکن شهر تهران توریع شد. در این تحقیق با استفاده از تخمین دو مدل لجستیک و به دست آوردن ضریب همبستگی میان تقاضای بیمه درمان تکمیلی و رخداد خسارت به بررسی موضوع مورد نظر پرداخته شده است....
15 صفحه اولPrioritizing the Factors Affecting Evidence-based Medicine in Physicians Affiliated to Iranian Health Insurance
Introduction: The utilization of the medical research results is one of the most important indicators in the development of this profession, which provides effective care to patients and improves the quality of care. However, performing based on the evidence-based results has been unsuccessful in some cases. This study aimed to investigated and prioritize the factors affecting evidence-based me...
متن کاملDoes Physician Dispensing Increase Drug Expenditures? Empirical Evidence from Switzerland.
This paper analyzes whether the opportunity for physicians to dispense drugs increases healthcare expenditures. We study the case of Switzerland, where dispensing physicians face financial incentives to overprescribe and sell more expensive pharmaceuticals. Using comprehensive physician-level data, we exploit the regional variation in the dispensing regime to estimate causal effects. The empiri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Risks
سال: 2022
ISSN: ['2227-9091']
DOI: https://doi.org/10.3390/risks10100187